These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 31289857

  • 21. 5-HT1A receptor activation counteracts c-Fos immunoreactivity induced in serotonin neurons of the raphe nuclei after immobilization stress in the male rat.
    Rioja J, Santín LJ, Doña A, de Pablos L, Minano FJ, Gonzalez-Baron S, Aguirre JA.
    Neurosci Lett; 2006 Apr 24; 397(3):190-5. PubMed ID: 16406667
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF, Lesourd M, Mocaer E, Koolhaas JM.
    J Pharmacol Exp Ther; 1999 Mar 24; 288(3):1125-33. PubMed ID: 10027850
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Sex hormone-dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter.
    Bouali S, Evrard A, Chastanet M, Lesch KP, Hamon M, Adrien J.
    Eur J Neurosci; 2003 Oct 24; 18(8):2203-12. PubMed ID: 14622181
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Activation of somatodendritic 5-HT1A autoreceptors reduces the acquisition and expression of cued fear in the rat fear-potentiated startle test.
    Zhao Y, Bijlsma EY, Ter Heegde F, Verdouw MP, Garssen J, Newman-Tancredi A, Groenink L.
    Psychopharmacology (Berl); 2019 Apr 24; 236(4):1171-1185. PubMed ID: 30539269
    [Abstract] [Full Text] [Related]

  • 28. Sexually dimorphic urethral activity in response to pharmacological activation of 5-HT1A receptors in the rat.
    Fan WJ, Li YT, Chen JJ, Chen SC, Lin YS, Kou YR, Peng CW.
    Am J Physiol Renal Physiol; 2013 Nov 01; 305(9):F1332-42. PubMed ID: 24049146
    [Abstract] [Full Text] [Related]

  • 29. Improving voiding efficiency in the diabetic rat by a 5-HT1A serotonin receptor agonist.
    Gu B, Wu G, Si J, Xu Y, Andersson KE.
    Neurourol Urodyn; 2012 Jan 01; 31(1):168-73. PubMed ID: 21780177
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.
    Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A.
    Eur J Pharmacol; 1995 Jul 25; 281(1):81-8. PubMed ID: 8566121
    [Abstract] [Full Text] [Related]

  • 32. Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.
    Fletcher PJ, Zeeb FD, Browne CJ, Higgins GA, Soko AD.
    Psychopharmacology (Berl); 2017 Mar 25; 234(5):889-902. PubMed ID: 28097374
    [Abstract] [Full Text] [Related]

  • 33. Activation of 5-HT₁A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease.
    Sun YN, Wang T, Wang Y, Han LN, Li LB, Zhang YM, Liu J.
    Neuropharmacology; 2015 Aug 25; 95():181-91. PubMed ID: 25797491
    [Abstract] [Full Text] [Related]

  • 34. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R, De Vry J.
    Eur J Pharmacol; 1993 Nov 16; 249(3):341-51. PubMed ID: 7904566
    [Abstract] [Full Text] [Related]

  • 35. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug 16; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 36. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM, Vilaró MT, Mengod G, Artigas F.
    J Neurochem; 1999 Jan 16; 72(1):262-72. PubMed ID: 9886078
    [Abstract] [Full Text] [Related]

  • 37. Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications.
    Ba M, Kong M, Ma G, Yang H, Lu G, Chen S, Liu Z.
    Brain Res; 2007 Jan 05; 1127(1):177-84. PubMed ID: 17113046
    [Abstract] [Full Text] [Related]

  • 38. Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects.
    Strauss CV, Vicente MA, Zangrossi H.
    Behav Brain Res; 2013 Jun 01; 246():103-10. PubMed ID: 23499701
    [Abstract] [Full Text] [Related]

  • 39. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist.
    Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, Gozlan H, Hamon M, Dourish CT.
    Behav Brain Res; 1996 Jun 01; 73(1-2):337-53. PubMed ID: 8788530
    [Abstract] [Full Text] [Related]

  • 40. Role of 5-HT1A Receptor in the Anxiolytic-Relaxant Effects of Bergamot Essential Oil in Rodent.
    Rombolà L, Scuteri D, Watanabe C, Sakurada S, Hamamura K, Sakurada T, Tonin P, Corasaniti MT, Bagetta G, Morrone LA.
    Int J Mol Sci; 2020 Apr 09; 21(7):. PubMed ID: 32283606
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.